Scholars Central

Case reportPublished 2014

Bilateral Anotia with Exposure to Retinoic Acid during Pregnancy

Authors: Atis A, Acar D, Talmac M, Polat I, Yilmaz E, Gedikbasi A

Journal of Clinical Case Reports

Volume 4 · Issue 4 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Isotretinoin (13-cis retinoic acid) is the most potent known inhibitor of sebum production and is by far one of the most effective antiacne medications for the treatment of severe and scarring acne, but it has been shown to be teratogenic when used during pregnancy. The risk of malformations in the population is 3-5%, but it has been reported to increase to almost 30% in women exposed to isotretinoin.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Case Reports
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Atis A”
  • BylineArticles whose byline prints “Acar D”
  • BylineArticles whose byline prints “Talmac M”
  • BylineArticles whose byline prints “Polat I”
  • BylineArticles whose byline prints “Yilmaz E”
  • BylineArticles whose byline prints “Gedikbasi A”